CY-1747
N/A
Report date: 2022/08/23 20:00:44
Base Information
Drug NameCY-1747
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEpimmune Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesSumitomo Pharmaceuticals Co LtdEpimmune Inc
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A